Comparing single vs multiple eye injections for diabetic cataract surgery patients
Treatments studied
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study compares giving one versus multiple anti-VEGF injections (a medicine that reduces abnormal blood vessel growth) around the time of cataract surgery in people with diabetes. It aims to see which approach better protects the eye and improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older and have diabetes.
- You have a cataract (cloudy lens) and a type of diabetic eye disease called non-proliferative diabetic retinopathy (early stage, no new blood vessel growth).
- You have not had eye surgery, laser treatment, or anti-VEGF injections in the study eye in the past 6 months.
- You have not had eye inflammation (uveitis), glaucoma, or a cataract so advanced that the doctor cannot see the back of your eye.
- Your blood sugar control is good (HbA1c of 9% or lower).
- You are not pregnant or breastfeeding, and you have not had a stroke or heart attack in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether one eye injection (aflibercept) works better than another (bevacizumab) for people with diabetic macular edema. Both are already used for this condition, and the goal is to see which provides better vision improvement.
This study compares two injectable medications (faricimab and biosimilar ranibizumab) used to treat diabetic retinopathy, a serious eye condition that can cause vision loss in people with diabetes. The trial will measure how well each medication works and track specific markers in your eye to understand treatment response.
This trial tests a high-dose version of the drug aflibercept (given as an eye injection) for people with diabetic macular edema who have previously had a vitrectomy surgery. The goal is to see if this higher dose can help reduce swelling and improve vision.
This trial tests whether combining a steroid implant (dexamethasone) with an anti-VEGF injection (aflibercept) works better than the injection alone for people with diabetic macular edema who haven't been treated yet. It aims to improve vision and reduce retinal swelling.
This study tests an experimental eye injection (OLN324) for people with diabetic macular edema, a condition where swelling in the back of the eye causes vision loss. The goal is to see if the injection can improve vision.
This trial tests an eye injection called OLN324 for diabetic macular edema, a condition where fluid builds up in the retina and blurs vision. The treatment aims to improve vision and reduce swelling in the eye.
Hear when a new Cataract trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.